Carmana Giacomantonio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Researchers found that second-line immunosuppression for severe immune-related adverse events was associated with impaired survival outcomes among patients with advanced melanoma.

New jerseyUnited statesShailender bhatiaCarmana giacomantonioAndrew pecoraHackensack meridian john theurer cancer centerFred hutchinson cancer centerCelularity incDalhousie universityDutch melanoma treatment registryHackensack meridianJohn theurer cancer centerNova scotiaMalignant melanomaSkin cancerAlignant skin neoplasm